AI assistant
Cigna Group — Director's Dealing 2025
Mar 5, 2025
29918_dirs_2025-03-04_082400e1-3caf-4013-8fe2-574116979b98.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cigna Group (CI)
CIK: 0001739940
Period of Report: 2025-02-28
Reporting Person: BRAILER DAVID J (EVP & Chief Health Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-28 | Common Stock, $.01 Par Value | A | 6540.0000 | $0.0000 | Acquired | 15582.0000 | Direct |
| 2025-02-28 | Common Stock, $.01 Par Value | A | 5640.0000 | $0.0000 | Acquired | 21222.0000 | Direct |
| 2025-02-28 | Common Stock, $.01 Par Value | F | 775.0000 | $305.8600 | Disposed | 20447.0000 | Direct |
| 2025-02-28 | Common Stock, $.01 Par Value | F | 2632.0000 | $305.8600 | Disposed | 17815.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-28 | Employee Stock Option (Right to Buy) | $305.8550 | A | 23222.0000 | Acquired | 2035-02-28 | Common Stock, $.01 Par Value (23222.0000) | Direct |
Footnotes
F1: These restricted shares vest in full on March 1, 2026.
F2: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2022-2024 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
F3: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
F4: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.
F5: This option vests in full on March 1, 2026.